BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9456095)

  • 1. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations.
    Suzuki K; Sawa Y; Kadoba K; Takahashi T; Ichikawa H; Kagisaki K; Ohata T; Matsuda H
    Ann Thorac Surg; 1998 Jan; 65(1):54-8. PubMed ID: 9456095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The earlier detection of myocardial damage in open heart surgery using serum human heart fatty acid-binding protein].
    Suzuki K; Sawa Y; Kadoba K; Ichikawa H; Kagisaki K; Ohata T; Asayama K; Ohkaru Y; Matsuda H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Jun; 44(6):760-4. PubMed ID: 8753083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients.
    Fransen EJ; Maessen JG; Hermens WT; Glatz JF
    Ann Thorac Surg; 1998 Jan; 65(1):48-53. PubMed ID: 9456094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery.
    Hayashida N; Chihara S; Akasu K; Oda T; Tayama E; Kai E; Kawara T; Aoyagi S
    Jpn Circ J; 2000 Jan; 64(1):18-22. PubMed ID: 10651201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of renal function on serum and urinary heart fatty acid-binding protein levels.
    Nayashida N; Chihara S; Tayama E; Akasu K; Kai E; Kawara T; Aoyagi S
    J Cardiovasc Surg (Torino); 2001 Dec; 42(6):735-40. PubMed ID: 11698938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients.
    Fransen EJ; Maessen JG; Hermens WT; Glatz JF; Buurman WA
    Cardiovasc Res; 2000 Mar; 45(4):853-9. PubMed ID: 10728410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.
    Hasegawa T; Yoshimura N; Oka S; Ootaki Y; Toyoda Y; Yamaguchi M
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1697-702. PubMed ID: 15173726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting.
    Petzold T; Feindt P; Sunderdiek U; Boeken U; Fischer Y; Gams E
    Eur J Cardiothorac Surg; 2001 Jun; 19(6):859-64. PubMed ID: 11404143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
    de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
    Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction.
    Tanaka T; Hirota Y; Sohmiya K; Nishimura S; Kawamura K
    Clin Biochem; 1991 Apr; 24(2):195-201. PubMed ID: 2040092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction.
    Ghani F; Wu AH; Graff L; Petry C; Armstrong G; Prigent F; Brown M
    Clin Chem; 2000 May; 46(5):718-9. PubMed ID: 10794758
    [No Abstract]   [Full Text] [Related]  

  • 13. Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein.
    Sorichter S; Mair J; Koller A; Pelsers MM; Puschendorf B; Glatz JF
    Br J Sports Med; 1998 Jun; 32(2):121-4. PubMed ID: 9631217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.
    Glatz JF; Kleine AH; van Nieuwenhoven FA; Hermens WT; van Dieijen-Visser MP; van der Vusse GJ
    Br Heart J; 1994 Feb; 71(2):135-40. PubMed ID: 8130020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart-type fatty acid-binding protein (H-FABP)].
    Okamoto F; Sohmiya K; Tanaka T; Kitaura Y; Ohkaru Y
    Nihon Rinsho; 1999 Aug; 57 Suppl():261-4. PubMed ID: 10503416
    [No Abstract]   [Full Text] [Related]  

  • 16. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein.
    Van Nieuwenhoven FA; Kleine AH; Wodzig WH; Hermens WT; Kragten HA; Maessen JG; Punt CD; Van Dieijen MP; Van der Vusse GJ; Glatz JF
    Circulation; 1995 Nov; 92(10):2848-54. PubMed ID: 7586251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.
    Kleine AH; Glatz JF; Van Nieuwenhoven FA; Van der Vusse GJ
    Mol Cell Biochem; 1992 Oct; 116(1-2):155-62. PubMed ID: 1480144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia.
    Tambara K; Fujita M; Miyamoto S; Doi K; Nishimura K; Komeda M
    Int J Cardiol; 2004 Feb; 93(2-3):281-4. PubMed ID: 14975559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.
    Wodzig KW; Kragten JA; Modrzejewski W; Górski J; van Dieijen-Visser MP; Glatz JF; Hermens WT
    Clin Chim Acta; 1998 Apr; 272(2):209-23. PubMed ID: 9641361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.
    Nakata T; Hashimoto A; Hase M; Tsuchihashi K; Shimamoto K
    Cardiology; 2003; 99(2):96-104. PubMed ID: 12711885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.